Previous 10 | Next 10 |
Updating its Tactical U.S. Equity Themes, UBS introduced a new theme of Selloff Opporutunities. The screen "highlights a list of companies that look attractive following recent market volatility." "We believe some stocks have been unfairly punished in the sell-off," UBS' theme team wrote in a...
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) has been named to FORTUNE magazine’s “World’s Most Admired Companies” list for the fifth consecutive year. This year, IQVIA secured the first place ranking in FORTUNE’s Healthcare: Pharmacy and ...
IQVIA Holdings Inc. (“IQVIA”) (NYSE: IQV) will announce its fourth-quarter and full-year 2021 financial results before the market opens on Tuesday, February 15, 2022. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that d...
IQVIA (NYSE:IQV) today announced the appointment of Sheila A. Stamps to its board of directors, effective today. Ms. Stamps brings more than four decades of strategic, governance and operational management experience. During her extensive career she held senior executive leadership posi...
IQVIA (NYSE:IQV), a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, announced the appointment of Leslie Wims Morris to its board of directors, effective today. With more than 25 years of experience in financi...
James Star, the Executive Chairman of Canadian investment firm Longview Asset Management, purchased $1.79 million worth of Chewy shares. Chewy went on a roller coaster ride from its $22 IPO price in June 2019 to a high of nearly $120 by February 2021. The pandemic related tailwind...
Glenview Capital Management’s 13F portfolio value decreased from $5.96B to $5.46B this quarter. The number of positions decreased from 64 to 59. They increased Baxter International and Uber Technologies while decreasing ViacomCBS and dropping Walgreens Boots Alliance. The t...
The metaverse revolution is still just getting started, but talk about the new technology medium suddenly seems almost inescapable. The promise of virtual worlds as new settings for digital commerce and socialization could deliver big wins for leading companies, but investors shouldn't fixa...
The global medicine market — based on invoice price levels — is expected to grow at 3-6% CAGR through 2026. Medicine use and spending trends have been negatively impacted by the COVID-19 pandemic but will be more than offset by incremental spending on related vaccine...
Although the Healthcare sector is having a positive year in absolute terms, that isn't the case in relative terms. Biotech stocks are having a difficult year, in spite of many of those trading at dirt-cheap valuations that don't even reflect the cash they have in-hand. It's very l...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 10:00:13 ET Jailendra Singh from Truist Financial issued a price target of $300.00 for IQV on 2024-07-23 09:26:00. The adjusted price target was set to $300.00. At the time of the announcement, IQV was trading at $240.265. The overall price target consensus is...
2024-07-23 10:00:11 ET Elizabeth Anderson from Evercore ISI issued a price target of $270.00 for IQV on 2024-07-23 08:59:00. The adjusted price target was set to $270.00. At the time of the announcement, IQV was trading at $239.5. The overall price target consensus is at...
2024-07-23 07:00:06 ET Luke Sergott from Barclays issued a price target of $275.00 for IQV on 2024-07-23 05:25:00. The adjusted price target was set to $275.00. At the time of the announcement, IQV was trading at $245.23. The overall price target consensus is at $273.93 ...